AncestryDNA: The World’s Largest Genetic Database and What It Means for Health Discovery

With over 20 million people genotyped, AncestryDNA holds the largest consumer genetic database on Earth. But its focus remains firmly on genealogy, not health. Where does this test fit in the genomic landscape?

Presented By Our Partners

In 2012, a team at Ancestry.com launched a saliva-based DNA test designed not for hospitals or research institutions but for the millions of family history enthusiasts who had spent years building family trees from census records, ship manifests, and church registries. Within a decade, AncestryDNA had genotyped over 20 million people, creating the largest consumer genetic database in the world and fundamentally changing how people understand their heritage. The test has reunited adoptees with biological families, revealed hidden family connections across continents, and corrected long-held assumptions about ethnic identity. But in a genomic era where biological age testing, BRCA screening, and pharmacogenomics are reshaping preventive medicine, AncestryDNA occupies an interesting position: it collects the same type of genetic data (SNP genotyping) that health-focused competitors use to generate disease risk reports, yet it has chosen to focus almost exclusively on ancestry and genealogy. Understanding what AncestryDNA does, what it does not do, and what its data could theoretically reveal is essential for consumers navigating the expanding landscape of at-home genetic testing.

What Is AncestryDNA?

AncestryDNA is a direct-to-consumer genetic testing service that uses a saliva sample to perform SNP (single nucleotide polymorphism) genotyping across hundreds of thousands of genetic positions. The test costs $99 and requires no physician order or lab visit. Users collect saliva at home, mail the sample to Ancestry’s CLIA-certified laboratory, and receive results through the Ancestry website or app within 6 to 8 weeks.

The core product delivers an ethnicity estimate that breaks down the user’s ancestry by geographic region, a list of DNA matches (other AncestryDNA customers who share genetic segments), and integration with Ancestry’s genealogical records platform, which includes billions of historical documents. The ethnicity estimate is continuously updated as the company’s reference panels grow and its algorithms improve. DNA matches are ranked by estimated relationship proximity, and the platform provides tools for exploring shared ancestors and building family trees based on genetic connections.

AncestryDNA previously offered a health component (AncestryHealth) that provided FDA-authorized reports on certain hereditary conditions, but this product was discontinued. The current AncestryDNA product does not include health predisposition reports, carrier status, pharmacogenomics, or any disease risk information. However, users can download their raw genotype data and upload it to third-party health analysis platforms (such as SelfDecode, Promethease, or Genetic Genie) to generate health-related reports from the same underlying SNP data.

The Science Behind It: Population Genetics and the Health Data Beneath Ancestry

AncestryDNA’s genotyping technology is fundamentally similar to what health-focused services like 23andMe use: a microarray chip that reads specific SNP positions across the genome. The difference lies in how the data is analyzed and presented, not in the raw genetic information collected. Both platforms capture hundreds of thousands of genetic variants; the distinction is which variants they report on and how they package the results.

Population genetics, the scientific discipline underlying ancestry analysis, examines how genetic variation is distributed across human populations and how it has shifted through migration, selection, and genetic drift over thousands of years. AncestryDNA’s ethnicity estimates are generated by comparing a user’s SNP profile against reference panels, collections of genotype data from individuals with known, documented ancestry in specific geographic regions. As reference panels grow larger and more diverse, the precision of ethnicity estimates improves, which is why users frequently see their results change when Ancestry updates its algorithms.

The health implications of ancestry are often underappreciated. Certain genetic variants associated with disease risk are more prevalent in specific populations due to founder effects, genetic drift, and selective pressures. The three BRCA1/2 variants that 23andMe’s FDA-authorized test screens for, for example, are concentrated in Ashkenazi Jewish populations. Sickle cell trait is most common among individuals of West African descent. Tay-Sachs carrier status is elevated in both Ashkenazi Jewish and French-Canadian populations. Understanding one’s ancestry composition can inform which health screening tests are most relevant, even if the ancestry test itself does not provide health reports.

A 2022 systematic review published in Frontiers in Genetics by Shen et al. examined barriers to population genetic screening and found that 1% to 3% of the general population carries a clinically actionable genetic risk factor. The review highlighted that inadequate knowledge and perceived limited clinical utility were the primary barriers to genetic testing uptake. AncestryDNA’s enormous user base represents a population that has already overcome the initial barrier of submitting a DNA sample, yet most of these users have not accessed the health information their genotype data could reveal. That is the science. Here is how AncestryDNA applies it.

What AncestryDNA Does Well

AncestryDNA’s greatest asset is its database size. With over 20 million genotyped users, it offers the highest probability of finding genetic relatives among all DTC testing services. For adoptees, donor-conceived individuals, and anyone seeking biological family connections, this statistical advantage is decisive. The sheer scale of the database means that even relatively distant genetic matches (fourth or fifth cousins) are frequently identified, enabling family tree construction that would be impossible with smaller databases.

The integration with Ancestry’s genealogical records platform creates a uniquely powerful research environment. Users can move seamlessly between genetic matches and historical documents, census records, immigration records, and military files, building family narratives that combine molecular evidence with documentary evidence. No other platform offers this level of genetic-to-genealogical integration.

Featured Partner

Invest in the Infrastructure Behind Modern Medicine

As healthcare expands beyond hospital walls, the buildings and campuses supporting that shift are generating compelling returns for investors who move early. The Healthcare Real Estate Fund offers qualified investors direct access to a curated portfolio of medical office, outpatient, and specialty care facilities.

Learn More →

At $99, AncestryDNA is the most affordable major consumer genotyping service, making genetic testing accessible to a broad market. The ethnicity estimate, while not a health tool, provides a population-level context that can inform health decisions when combined with knowledge of population-specific genetic risks. The raw data download option gives users the flexibility to extract additional value from their genotype through third-party analysis services.

Pricing, Access, and Practical Realities

AncestryDNA costs $99 as a one-time purchase with no subscription required for the DNA test itself. However, full access to Ancestry’s genealogical records, historical documents, and family tree tools requires a separate Ancestry membership, which ranges from approximately $25 to $50 per month depending on the subscription tier. DNA results (ethnicity estimate, DNA matches) remain accessible without a membership, but the genealogical integration features are limited without one.

No physician order is required. The test is available to consumers aged 18 and older. Results are typically delivered within 6 to 8 weeks. AncestryDNA is not HSA or FSA eligible, as it is classified as a genealogy and general wellness product with no health diagnostic component. The test is not FDA authorized for any health claims.

Raw data can be downloaded in a standard format compatible with many third-party genetic analysis tools. This is an important feature for users who want to extract health-related insights from their genotype data without purchasing a separate health-focused test. However, third-party health reports generated from raw data uploads have not undergone the same FDA review process that 23andMe’s authorized health reports have, and their clinical reliability varies.

Who AncestryDNA Is Best For

AncestryDNA is the optimal choice for genealogy enthusiasts who want to combine genetic data with the world’s largest collection of historical records. It is the strongest platform for adoptees and donor-conceived individuals seeking biological relatives, due to its unmatched database size. Users who are primarily ancestry-curious and want the most affordable entry point into consumer genetics will find it delivers substantial value at $99. Those who want to use raw data for third-party health analysis can leverage AncestryDNA as a low-cost genotyping source, though the health reporting will come from separate platforms.

Those who should choose alternatives include anyone whose primary interest is health screening. Without FDA-authorized health reports, AncestryDNA provides no direct health information. Users concerned about hereditary cancer risk, carrier status, or pharmacogenomics should choose 23andMe ($229), Color Health ($249), or a clinical genetic testing service. Anyone seeking comprehensive genomic data should consider Nebula Genomics for whole genome sequencing. Users interested in biological aging and longevity metrics need epigenetic testing from TruDiagnostic, Elysium, or GlycanAge, which measure entirely different biomarkers (DNA methylation) than ancestry SNP arrays.

How AncestryDNA Compares

23andMe Health + Ancestry ($229) is the most direct competitor, offering both ancestry analysis and FDA-authorized health reports from a single saliva test. 23andMe’s database is smaller (approximately 14 million vs. AncestryDNA’s 20+ million), but its health reporting makes it the better all-in-one choice for users who want both ancestry and health information. For pure ancestry analysis and genealogical research, AncestryDNA’s larger database and integration with historical records make it the stronger platform.

MyHeritage DNA ($79 to $99) offers another ancestry-focused alternative with a strong international user base, particularly in Europe. FamilyTreeDNA ($79 to $249) provides more granular haplogroup analysis and Y-DNA/mtDNA testing that AncestryDNA and 23andMe do not offer, making it valuable for deep ancestry research. Nebula Genomics ($299 to $999) provides whole genome sequencing rather than SNP genotyping, delivering vastly more genetic data but without the genealogical record integration that makes AncestryDNA unique.

The competitive landscape reveals a clear segmentation: AncestryDNA leads in genealogy; 23andMe leads in consumer health genetics; Nebula leads in comprehensive genomic data; and specialized services (Color, GeneSight, TruDiagnostic) lead in specific clinical applications.

Limitations and Open Questions

The absence of health reports is the most obvious limitation for health-focused consumers. AncestryDNA collects genotype data that could generate health insights but chooses not to report them, leaving users to navigate third-party analysis tools of varying quality and reliability. The discontinued AncestryHealth product raised and then dashed expectations for an integrated health offering.

Ethnicity estimates, while fascinating, carry important caveats. They reflect the current state of reference panels, which are biased toward populations that have been heavily sampled (European, East Asian) and underrepresent others (African, South Asian, Indigenous). Users from underrepresented populations may receive less precise or less granular results. Ethnicity estimates are probabilistic, not definitive, and should be understood as approximations that will continue to change as reference panels expand.

Privacy concerns are relevant for any genetic testing service. AncestryDNA stores genetic data on its servers, and users should review the company’s privacy policies regarding data sharing, law enforcement access, and third-party research use. Unlike Nebula Genomics, which emphasizes privacy-first architecture and user data ownership, Ancestry’s business model includes monetizing genealogical subscriptions and, historically, participating in genetic research partnerships. Users should make informed decisions about the long-term implications of placing their genetic data in any corporate database.

What This Means for Your Health

AncestryDNA is not a health product, but the data it collects has health implications that most users never explore. Understanding your ancestry composition can inform which population-specific genetic risks are most relevant to your health screening decisions. If your ancestry reveals significant Ashkenazi Jewish heritage, clinical BRCA testing becomes more urgent. If your results indicate West African ancestry, hemoglobin electrophoresis for sickle cell trait may be warranted. If European ancestry predominates, hereditary hemochromatosis screening may be relevant.

Within Healthcare Discovery‘s longevity framework, genetic ancestry represents one input into a much larger equation. The Four Shadows of cardiovascular disease, cancer, neurodegenerative disease, and metabolic dysfunction all have genetic components, but the Five Pillars of Nutrition, Sleep, Movement, Breathwork, and Mindset remain the primary levers that individuals can control. Knowing your ancestry can sharpen the questions you ask your healthcare provider and the screening tests you prioritize, but it does not change the fundamental prescription: foundational health practices, consistently applied, are the most powerful tools for extending healthspan regardless of genetic background.

The practical recommendation: if your primary goal is genealogy and family discovery, AncestryDNA is the best platform available. If your primary goal is health information, spend the additional $130 for 23andMe Health + Ancestry, or invest in targeted clinical screening through your healthcare provider. If you already have AncestryDNA data, consider downloading your raw genotype file and uploading it to a third-party health analysis platform to extract additional value from the test you have already taken.

Frequently Asked Questions

Does AncestryDNA include health reports?
No. AncestryDNA currently focuses exclusively on ancestry composition, ethnicity estimates, and DNA relative matching. The company previously offered AncestryHealth with FDA-authorized health predisposition reports, but this product has been discontinued. Users who want health information from their AncestryDNA data can download raw genotype files and upload them to third-party analysis platforms, though these reports are not FDA-reviewed.

How does AncestryDNA compare to 23andMe for health information?
23andMe Health + Ancestry ($229) includes FDA-authorized health predisposition reports (BRCA1/2, APOE/Alzheimer’s, carrier status, pharmacogenomics) that AncestryDNA ($99) does not offer. For users who want both ancestry and health data from a single test, 23andMe is the better choice. AncestryDNA’s advantages are its larger database (20+ million vs. 14 million users) and superior integration with genealogical records for family history research.

Can I upload my AncestryDNA data to get health reports?
Yes. AncestryDNA allows users to download their raw genotype data, which can then be uploaded to third-party analysis platforms such as SelfDecode, Promethease, or Genetic Genie to generate health-related reports. These third-party reports have not been FDA-reviewed, and their clinical reliability varies. This approach lets you extract additional value from your $99 AncestryDNA test without purchasing a separate health-focused genetic test.

Why is AncestryDNA’s database important?
With over 20 million genotyped users, AncestryDNA offers the highest statistical probability of finding genetic relatives among all consumer DNA testing services. This is critical for adoptees seeking biological families, donor-conceived individuals, and anyone researching family connections. Larger databases increase the likelihood of matching even with relatively distant relatives (fourth to sixth cousins), enabling family tree construction that smaller databases cannot support.

Is AncestryDNA accurate for ethnicity estimates?
AncestryDNA’s ethnicity estimates are probabilistic approximations based on comparison against reference panels of individuals with known ancestry. Accuracy varies by population: well-sampled populations (European, East Asian) generally receive more precise and granular estimates than underrepresented populations (certain African, South Asian, and Indigenous groups). Estimates are updated periodically as reference panels expand and algorithms improve, which means your results may change over time. Ethnicity estimates should be understood as educated approximations, not definitive statements of heritage.

Free Daily Briefing

The Latest Longevity Science.
Delivered Every Morning.

Join researchers, physicians, and health professionals getting daily breakthroughs in AI-driven medicine, epigenetics, and longevity research.

Support the research that powers this editorial

Subscribe Free

No spam. Unsubscribe anytime. We respect your inbox.